KM Financial Solutions | South African drugmaker Aspen secures 3.4 billion euro credit line
17338
post-template-default,single,single-post,postid-17338,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

South African drugmaker Aspen secures 3.4 billion euro credit line

South African drugmaker Aspen secures 3.4 billion euro credit line

JOHANNESBURG, May 17 (Reuters) – Aspen Pharmacare,
Africa’s biggest generic drugmaker, said on Thursday it had
secured a 3.4 billion euro ($4 billion) credit facility for
refinancing debt at three of its subsidiaries.

No Comments

Sorry, the comment form is closed at this time.